Results 51 to 60 of about 15,580 (252)

A simple tool with which to study the course of chronic hand eczema in clinical practice: a reduced-item score [PDF]

, 2013
Background Physicians need a simple, disease-specific tool with which to assess disease severity and the effect of therapeutic intervention in patients with chronic hand eczema.
Donders, Rogier, Boot, C.R.L., Evers, Andrea W. M., Robin F. van Gils, Boot, Cecile R. L., Anema, Johannes R., Rustemeyer, T., Willem van Mechelen, Johannes R. Anema, Coenraads, P.J., Cécile R. L. Boot, Evers, A.W.M., Alkemade, Hans A. C., Pieter Jan Coenraads, Rustemeyer, Thomas, Valk, P.G.M. van der, Gils, R.F. van, van Gils, Robin F., Thomas Rustemeyer, Alkemade, H.A., Coenraads, Pieter Jan, Hans A. C. Alkemade, van der Valk, Pieter G. M., Pieter G. M. van der Valk, Andrea W. M. Evers, Anema, J.R., Mechelen, W. van, Donders, A.R.T., van Mechelen, Willem, Rogier Donders   +29 more
core   +1 more source

Association of Adult Atopic Dermatitis Severity With Bacterial, Viral, and Fungal Skin Infections

, 2023
Little is known about the relationship of atopic dermatitis (AD) severity, phenotype, and persistence on different types of skin infections. To evaluate the relationship of AD characteristics and skin infections over time in adults.
Silverberg, Jonathan I, Jorge A. Rios-Duarte, Rios-Duarte, Jorge A, Jonathan I. Silverberg   +3 more
core   +1 more source

Successful Co‐Administration of Secukinumab and Dupilumab in a Patient With Psoriasis and Paradoxical Atopic Dermatitis

JEADV Clinical Practice, EarlyView.
ABSTRACT Paradoxical atopic dermatitis (AD) can arise during biologic therapy for psoriasis due to an immune‐axis imbalance. We describe a 47‐year‐old man who developed severe AD while receiving secukinumab, which was successfully managed with the addition of dupilumab, allowing long‐term control of both diseases.
So Yun Park, Minjung Park, Ho Eun Gwang, Narang Hong, Hye Jung Jung, Mi Youn Park, Jiyoung Ahn   +6 more
wiley   +1 more source

Anti-CD20 (rituximab) treatment improves atopic eczema

, 2008
BACKGROUND: Atopic eczema (AE) is a chronic inflammatory skin disorder characterized by eczematous skin lesions, pruritus, and typical histopathologic features.
Simon, Hans-Uwe, Nikhil Yawalkar, Kostylina, Ganna, Hans-Uwe Simon, Hösli, Susanne, Dagmar Simon, Susanne Hösli, Simon, Dagmar, Yawalkar, Nikhil, Ganna Kostylina, Hösli S, Simon HU, Yawalkar N, Simon D, Kostylina G   +14 more
core   +1 more source

Startups Driving Artificial Intelligence Into Clinical Dermatology

JEADV Clinical Practice, EarlyView.
ABSTRACT Artificial intelligence (AI) is rapidly transitioning from innovation to routine clinical application in dermatology. This review examines how AI‐enabled technologies are being developed and integrated across diverse clinical purposes and workflows.
Dominique Du Crest, Benjamin Miguel Monteagudo, Stanislas Vandier, Mullarkey Dan, Svedenhag Per, Jon Friis, Monisha Madhumita, Lilit Garibyan, Tu‐Anh Duong, Merete Haedersdal, Vinzent Kevin Ortner   +10 more
wiley   +1 more source

Itching in Atopic Dermatitis: Patient- and Physician-reported Outcomes in the German Atopic Dermatitis Registry TREATgermany

Acta Dermato-Venereologica, 2023
TREATgermany is an investigator-initiated prospective disease registry. It investigates physician- and patient-reported disease severity (Eczema Area and Severity Index (EASI), objective Scoring Atopic Dermatitis (oSCORAD), Investigator Global Assessment,
Elke Weisshaar, Philipp Bentz, Christian Apfelbacher, Eva Haufe, Luise Heinrich, Annice Heratizadeh, Susanne Abraham, Inken Harder, Andreas Kleinheinz, Andreas Wollenberg, Knut Schäkel, Franca Wiemers, Julia Ertner, Matthias Augustin, Julia Wildberger, Ralph von Kiedrowski, Margitta Worm, Alexander Zink, Isaak Effendy, Andrea Asmussen, Mario Pawlak, Michael Sticherling, Melanie Hilgers, Christiane Handrick, Sven Quist, Beate Schwarz, Magnus Bell, Petra Staubach-Renz, Sung-Hei Hong-Weldemann, Bernhard Homey, Jens-Joachim Brücher, Stephan Weidinger, Thomas Werfel, Jochen Schmitt   +33 more
doaj   +1 more source

Refractory Eczema as a Presenting Feature of Common Variable Immunodeficiency

JEADV Clinical Practice, EarlyView.
ABSTRACT Common variable immunodeficiency (CVID) is the most prevalent symptomatic inborn error of immunity (IEI) in adults. It presents with recurrent infections and non‐infectious complications, including autoimmunity, lymphoproliferation and dermatitis.
Mercedes Sanchez‐Diaz, Lars Matthies, Andrea Vanegas Ramirez   +2 more
wiley   +1 more source

Nail Lichen Planus in Children ‐ Epidemiology, Pathogenesis, Clinical Presentation, and Treatment

JEADV Clinical Practice, EarlyView.
ABSTRACT Nail lichen planus (NLP) is a chronic inflammatory disorder that, while rare in children compared to adults, represents a significant cause of pediatric nail dystrophy that requires early recognition to prevent permanent scarring and nail loss.
Francesca Pampaloni, Matilde Iorizzo
wiley   +1 more source

Emerging Role of Janus Kinase Inhibitors for the Treatment of Atopic Dermatitis

ImmunoTargets and Therapy, 2020
Rhea Singh,1 Courtney E Heron,1 Rima I Ghamrawi,1 Lindsay C Strowd,1 Steven R Feldman1– 4 1Center for Dermatology Research, Department of Dermatology, Wake Forest School of Medicine, Winston-Salem, NC, USA; 2Department of Pathology, Wake Forest ...
Singh R, Heron CE, Ghamrawi RI, Strowd LC, Feldman SR   +4 more
doaj  

Baricitinib provides rapid and sustained improvements in absolute EASI and SCORAD outcomes in adults with moderate-to-severe atopic dermatitis

Journal of Dermatological Treatment, 2023
Background Baricitinib is an oral selective Janus kinase 1/2 inhibitor approved for moderate-to-severe atopic dermatitis (AD) in adults. Objectives To evaluate absolute Eczema Area and Severity Index (EASI) and SCORing of Atopic Dermatitis (SCORAD ...
Jacob P. Thyssen, Thomas Bieber, C. Elise Kleyn, Audrey Nosbaum, Susanne Grond, Helmut Petto, Elisabeth Riedl, Andreas Wollenberg   +7 more
doaj   +1 more source